[go: up one dir, main page]

DE60032704D1 - Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit - Google Patents

Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit

Info

Publication number
DE60032704D1
DE60032704D1 DE60032704T DE60032704T DE60032704D1 DE 60032704 D1 DE60032704 D1 DE 60032704D1 DE 60032704 T DE60032704 T DE 60032704T DE 60032704 T DE60032704 T DE 60032704T DE 60032704 D1 DE60032704 D1 DE 60032704D1
Authority
DE
Germany
Prior art keywords
film
coated tablets
influence susceptibility
dependence
minimized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60032704T
Other languages
English (en)
Other versions
DE60032704T2 (de
Inventor
Peter Fyhr
Marta Corselli
Staffan Waxegard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Laboratories UT Inc
Original Assignee
Actavis Laboratories UT Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Laboratories UT Inc filed Critical Actavis Laboratories UT Inc
Application granted granted Critical
Publication of DE60032704D1 publication Critical patent/DE60032704D1/de
Publication of DE60032704T2 publication Critical patent/DE60032704T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60032704T 1999-10-28 2000-10-11 Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit Expired - Fee Related DE60032704T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903879 1999-10-28
SE9903879A SE9903879D0 (sv) 1999-10-28 1999-10-28 Multipor food protection

Publications (2)

Publication Number Publication Date
DE60032704D1 true DE60032704D1 (de) 2007-02-15
DE60032704T2 DE60032704T2 (de) 2007-10-11

Family

ID=20417507

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032704T Expired - Fee Related DE60032704T2 (de) 1999-10-28 2000-10-11 Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit

Country Status (5)

Country Link
EP (1) EP1095651B1 (de)
JP (1) JP4711499B2 (de)
DE (1) DE60032704T2 (de)
ES (1) ES2280192T3 (de)
SE (1) SE9903879D0 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005104914A (ja) * 2003-09-30 2005-04-21 Kyowa Yakuhin Kogyo Kk 塩基性薬剤含有製剤
NZ556630A (en) * 2005-01-27 2010-12-24 Alembic Ltd Extended release formulation of levetiracetam including a hydrophilic rate controlling polymer
CN101212953A (zh) * 2005-03-29 2008-07-02 麦克内尔-Ppc股份有限公司 具有疏水介质中的亲水药物的组合物
EP2714015B1 (de) * 2011-06-01 2017-03-15 FMC Corporation Feste dosierungsformen mit gesteuerter freisetzung
WO2014158660A1 (en) 2013-03-14 2014-10-02 Dow Global Technologies Llc Composite polyamide membrane including dissolvable polymer coating
WO2022014601A1 (ja) * 2020-07-13 2022-01-20 キリンホールディングス株式会社 フィルムコーティング錠剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
DE3573884D1 (en) * 1982-07-08 1989-11-30 Leo Ab Substained release tablets and method for preparation thereof
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
SK279684B6 (sk) * 1993-06-14 1999-02-11 Janssen Pharmaceutica N.V. Tableta a spôsob jej výroby
DK171127B1 (da) * 1994-04-22 1996-06-24 Gea Farmaceutisk Fabrik As Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor

Also Published As

Publication number Publication date
SE9903879D0 (sv) 1999-10-28
EP1095651B1 (de) 2007-01-03
JP4711499B2 (ja) 2011-06-29
DE60032704T2 (de) 2007-10-11
JP2001131059A (ja) 2001-05-15
ES2280192T3 (es) 2007-09-16
EP1095651A2 (de) 2001-05-02
EP1095651A3 (de) 2002-08-21

Similar Documents

Publication Publication Date Title
NO20011085D0 (no) Tablett med umiddelbar frigivningsvirkning
BR0012206B1 (pt) artigo fotocrâmico revestido e artigo fotocrâmico.
BR9917075B1 (pt) artigo e artigo fotocrÈmico.
BR9917076B1 (pt) artigo e artigo fotocrÈmico.
ATE268165T1 (de) Didanosin tabletten mit magensaftresistentem überzug
BR9917067B1 (pt) artigo fotocrÈmico.
DE60037606D1 (de) Rechner mit urladungsfähigem sicherem Programm
EP1042129A4 (de) Geschichteter gegenstand
DE60026297D1 (de) Pyrrolotriazin kinasehemmer
ATE279413T1 (de) Pyrazolobenzodiazepine mit cdk2 hemmender wirkung
ID26052A (id) Barang berdaya serap
DK0966287T3 (da) Oxacarbazepinfilmovertrukne tabletter
DE69425849D1 (de) Doppelverpackter leicht oxidierbarer Artikel
DE60039046D1 (de) Lebensmittelprodukte mit biokontrollierter konservierung
DE60009168D1 (de) Behälter mit informationsanzeige
ID23735A (id) Tablet trovafloksasin mesilat
FI20000976L (fi) Tuotteita
DE69823190D1 (de) Plattenspieler mit selbstschliessendem tablett
DE59905444D1 (de) Kochmulde mit anzeigeelementen
FI3513U1 (fi) Myyntiteline
DE60007063D1 (de) Einheit mit drehenden teilen
ATE327681T1 (de) Lebensmittel mit vereinzelten stärkekörnchen
DE69811027D1 (de) Zirkulator mit konzentrierten Elementen
ES1046088Y (es) Lavavajillas con cesto amovible.
DE60032704D1 (de) Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee